Bentham Science Logo

Track Your Manuscript:


Current Pharmaceutical Design

Volume 26, 46 Issues, 2020
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Current Pharmaceutical Design, Volume 14 - Number 31



Receptor Binding Ligands to Image Infection

, 14(31): 3316 - 3325

M. Chianelli, O. C. Boerman, G. Malviya, F. Galli, W. J.G. Oyen and A. Signore


DOI: 10.2174/138161208786549416



Growth Factor/Peptide Receptor Imaging for the Development of Targeted Therapy in Oncology

, 14(31): 3340 - 3347

Christophe Van de Wiele, Hendricus Boersma, Rudi A. Dierckx, Bart De Spiegeleer, Aren Van Waarde and Philip H. Elsinga


DOI: 10.2174/138161208786549434


Immunoscintigraphy as Potential Tool in the Clinical Evaluation of HER2/neu Targeted Therapy

, 14(31): 3348 - 3362

Eli C.F. Dijkers, Elisabeth G.E. de Vries, Jos G.W. Kosterink, Adrienne H. Brouwers and Marjolijn N. Lub-de Hooge


DOI: 10.2174/138161208786549425




Executive Editor

Atta-ur-Rahman, FRS
(29381 citations)
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
(UK)
Biography

View Full Editorial Board

Nobel Laureate on Editorial Board

Andrew V. Schally
(USA)

Journal History

Current Pharmaceutical Design was introduced in 1995 with the assistance of Dr. William A. Banks.
Scopus CiteScore Metrics: 2.32

Advertisement

PLANNING YOUR RESEARCH TO PUBLISH IN HIGH IMPACT JOURNALSSeptember Health DaysCovid Resource CenterCoronaviruses-JOIN-EDITORIAL-BOARD

Related Journals

Related eBooks

eBooks Catalog